Logo Image

Shorts

When to Use Checkpoint Inhibitors in Sarcoma Therapy
1:27
When to Use Checkpoint Inhibitors in Sarcoma Therapy
7 months ago
by
Seth M. Pollack, MD
Vanessa Almendro Navarro, PhD, MBA, encourages her colleagues to envision an ideal state of City of Hope as an organization as opposed to succumbing to the fear of change.
0:57
Overcoming Fear to Change in the Commercialization Aspect of Oncology
7 months ago
by
Vanessa Almendro Navarro, PhD, MBA
Irtiza N. Sheikh, DO, touched upon key questions that emerged following the publication of research evaluating liso-cel between patients younger than 50 and those 50 years and older in both the real-world and clinical trial settings.
1:13
Highlighting Key Questions in Liso-Cel Treatment Across Lymphoma Settings
7 months ago
by
Irtiza N. Sheikh, DO
Vanessa Almendro Navarro, PhD, MBA, highlighted the importance of collaboration between oncology departments to facilitate drug development for use in oncology care.
1:14
Collaboration Across Departments is Key in Oncology Development
7 months ago
by
Vanessa Almendro Navarro, PhD, MBA
Looking back at the long-term effects of the COVID-19 pandemic on oncology care, Daniel C. McFarland, DO, spoke with CancerNetwork® about how this health crisis impacted his interactions with patients from a psycho-oncology perspective.
0:36
COVID-19 Was ‘Added Layer of Trauma’ in Psycho-Oncology Care
7 months ago
by
Daniel C. McFarland, DO
Personalizing Diet Based on Patient Risk and Metabolism
0:49
Personalizing Diet Based on Patient Risk and Metabolism
7 months ago
by
Ifeoma Dikeocha, PhD
Irtiza N. Sheikh, DO, discussed key efficacy findings from a comparative analysis of liso-cel among patients younger than 50 with large B-cell lymphoma (LBCL) in the real-world and clinical trial settings.
0:50
Data Show Similar Liso-Cel Efficacy in Young LBCL Groups Across Settings
7 months ago
by
Irtiza N. Sheikh, DO
The Missing Link in Cancer Research: Diversity
0:38
The Missing Link in Cancer Research: Diversity
7 months ago
by
Kathie-Ann Joseph, MD, MPH, FACS
A study published in Lancet Oncology demonstrated that radiation is a feasible method to treat celiac plexus-associated pain in patients with gastrointestinal cancers.
0:57
Using Radiation to Treat Celiac Plexus-Associated Pain in GI Cancers
7 months ago
by
Michael Buckstein, MD, PhD
Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation
0:53
Revolutionizing Breast Cancer: From 7 Weeks to 1 Week of Radiation
7 months ago
by
Parul Barry
Beyond Mastectomy: The Power of Oncoplastic Surgery
0:38
Beyond Mastectomy: The Power of Oncoplastic Surgery
7 months ago
by
Kathie-Ann Joseph, MD, MPH, FACS
ACRO Day 2 Quick Take With CancerNetwork
1:52
ACRO Day 2 Quick Take With CancerNetwork
7 months ago
by
Ariana Pelosci(+1 more)
The Complex Decisions in Treating DCIS Breast Cancer
0:43
The Complex Decisions in Treating DCIS Breast Cancer
7 months ago
by
Jean L. Wright, MD, FASTRO
Yun Rose Li, MD, PhD, spoke about the inspiration behind her team’s assessment of cardiovascular risks with hormone therapy for prostate cancer in the phase 2 IMPACT-ADT trial.
1:27
STEMI Event Inspires Prostate Cancer Trial Assessing Cardiovascular Risk
7 months ago
by
Yun Rose Li, MD, PhD
As part of a conversation with a CancerNetwork®, Manoj Bhasin, PhD, MS, discussed the next steps for refining the development of next-generation therapies for patients with newly diagnosed multiple myeloma (NDMM) following novel translational findings that he and colleagues published in Nature Cancer.
0:48
Translating Cytogenetic Data Into Next-Generation Therapies in NDMM
7 months ago
by
Manoj Bhasin, PhD, MS
ACRO Day 1 Quick Take With CancerNetwork
0:48
ACRO Day 1 Quick Take With CancerNetwork
7 months ago
by
Ariana Pelosci(+1 more)
Yun Rose Li, MD, PhD, discussed a balancing act when considering treatment with hormone therapy for patients with late-stage prostate cancer, particularly those who are at a higher risk of cardiovascular events.
1:06
Balancing Cardiovascular and Prostate Cancer Risks in Oncology Treatment
7 months ago
by
Yun Rose Li, MD, PhD
In honor of World Cancer Day, Paolo Tarantino, MD, spoke with CancerNetwork® about the current state of the oncology field and how it may continue to evolve.
0:51
Social Media and AI Are Expanding With the Data in Oncology Research
7 months ago
by
Paolo Tarantino, MD, PhD
How Can Diet Improve Chemotherapy Results?
1:01
How Can Diet Improve Chemotherapy Results?
7 months ago
by
Ifeoma Dikeocha, PhD
Arturo Loaiza-Bonilla, MD, MSEd, FACP, touched upon studies such as the PANORAMA trial, which assessed early detection of pancreatic cancers through AI–assisted CT scans.
0:47
Employing Artificial Intelligence to Detect Early-Stage Pancreatic Cancer
7 months ago
by
Arturo Loaiza-Bonilla, MD, MSEd, FACP
What is Inflammatory Breast Cancer?
0:40
What is Inflammatory Breast Cancer?
7 months ago
by
Kathie-Ann Joseph, MD, MPH, FACS
Arturo Loaiza-Bonilla, MD, MSEd, FACP, discussed the ability of large foundational AI models to democratize pathology readouts by providing biomarkers with an H&E stain or a slide in the absence of readily available pathologist.
1:29
Democratizing Pathology in Oncology with Artificial Intelligence
7 months ago
by
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Neoadjuvant Radiation in Sarcoma: Does it Change Surgical Ease?
1:12
Neoadjuvant Radiation in Sarcoma: Does it Change Surgical Ease?
7 months ago
by
Emily J. Papai, MD
Why Early Dietary Support in Cancer is Vital
0:41
Why Early Dietary Support in Cancer is Vital
7 months ago
by
Ifeoma Dikeocha, PhD
In this video, Arturo Loaiza-Bonilla, MD, MSEd, FACP, discussed best use cases for artificial intelligence (AI) in oncology.
0:52
Outlining Best Use Cases For AI in Oncology
7 months ago
by
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Arturo Loaiza-Bonilla, MD, MSEd, FACP, discussed advances in the application of AI to oncology that he believes will have the potential to transform practice for patients undergoing treatment for cancer.
0:52
AI May Function Like “Connective Tissue” in the Clinical Oncology Continuum
7 months ago
by
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Brandon Mancini, MD, MBA, FACRO, introduces the RadOnc on the Run podcast, a program dedicated to discussing critical advances and considerations in radiation oncology care and research.
1:03
Introducing RadOnc on the Run: CancerNetwork’s New Podcast Initiative
7 months ago
by
Brandon Mancini, MD, MBA, FACRO
Soumen Das, MS, FACS, MRCS, FRCS, outlined 3 pillars for breast cancer the GBCI, a wing of the WHO outlined among other key performance indices (KPIs) for breast cancer care.
0:49
Aligning With the WHO GBCI: 3 Pillars for Breast Cancer Treatment
7 months ago
by
Soumen Das, MBBS, MS, FACS
Soumen Das, MS, FACS, MRCS, FRCS, discussed the integration of a breast cancer reporting and data system (BCRADS) for low- and middle-income countries to help improve outcomes in low resource settings (LRS).
0:46
Decentralizing Breast Oncology Care in LMIDs Through Clinical Reporting/Data System
7 months ago
by
Soumen Das, MBBS, MS, FACS
Surbhi Sidana, MD, associate professor of medicine and lead of the Myeloma CAR-T/Immunotherapy Program at Stanford University in California, discussed the importance of funding for hematologic oncology research in an interview with CancerNetwork®.
0:40
NIH Funding May Be Instrumental to Developing Multiple Myeloma Research
8 months ago
by
Surbhi Sidana, MD